These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26362747)

  • 1. Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases.
    Louthrenoo W
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):319-42. PubMed ID: 26362747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
    Vassilopoulos D; Calabrese LH
    Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
    Schwaneck EC; Krone M; Kreissl-Kemmer S; Weißbrich B; Weiss J; Tony HP; Gadeholt O; Schmalzing M; Geier A
    Clin Rheumatol; 2018 Nov; 37(11):2963-2970. PubMed ID: 30238380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.
    Harigai M; Mochida S; Mimura T; Koike T; Miyasaka N
    Mod Rheumatol; 2014 Jan; 24(1):1-7. PubMed ID: 24261752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Reactivation in Rheumatic Diseases: Screening and Prevention.
    Koutsianas C; Thomas K; Vassilopoulos D
    Rheum Dis Clin North Am; 2017 Feb; 43(1):133-149. PubMed ID: 27890170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis.
    Moghoofei M; Mostafaei S; Ashraf-Ganjouei A; Kavosi H; Mahmoudi M
    Microb Pathog; 2018 Jan; 114():436-443. PubMed ID: 29223453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases.
    Chakravarty EF
    Rheum Dis Clin North Am; 2017 Feb; 43(1):111-121. PubMed ID: 27890168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.
    Kato M; Atsumi T
    Rheumatol Int; 2016 May; 36(5):635-41. PubMed ID: 26573663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.
    Mori S; Fujiyama S
    World J Gastroenterol; 2015 Sep; 21(36):10274-89. PubMed ID: 26420955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of rheumatic diseases and hepatitis B virus coinfection.
    Felis-Giemza A; Olesińska M; Świerkocka K; Więsik-Szewczyk E; Haładyj E
    Rheumatol Int; 2015 Mar; 35(3):385-92. PubMed ID: 25549599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
    Lee YH; Bae SC; Song GG
    Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B.
    King LK; Lee A; Anandacoomarasamy A
    Intern Med J; 2012 May; 42(5):523-31. PubMed ID: 21790927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster infection, vaccination and immunocompromised rheumatology patients.
    O'Connor MB; Phelan MJ
    Rheumatol Int; 2013 Jan; 33(1):239-40. PubMed ID: 21947348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosupression and viral infections in rheumatic diseases].
    Vince A; Dusek D
    Reumatizam; 2007; 54(2):58-62. PubMed ID: 18351141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
    Fragoulis GE; Nikiphorou E; Dey M; Zhao SS; Courvoisier DS; Arnaud L; Atzeni F; Behrens GM; Bijlsma JW; Böhm P; Constantinou CA; Garcia-Diaz S; Kapetanovic MC; Lauper K; Luís M; Morel J; Nagy G; Polverino E; van Rompay J; Sebastiani M; Strangfeld A; de Thurah A; Galloway J; Hyrich KL
    Ann Rheum Dis; 2023 Jun; 82(6):742-753. PubMed ID: 36328476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review].
    Gridneva GI; Belov BS; Aronova ES
    Ter Arkh; 2024 Jun; 96(5):523-530. PubMed ID: 38829815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.